LZLiwei Zhang

Liwei Zhang

*This is an algorithmically generated author record based on publicly available information.

Liwei Zhang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Cong Zhang

    Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan 450052, China

    2 shared publications
  • Haoliang Wu

    Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan 450052, China

    2 shared publications
  • Bin Liu

    Department of Vascular Surgery

    1 shared publication
  • Boao Xie

    Zhengzhou University - Department of Vascular and Endovascular Surgery

    1 shared publication
  • Boao Xie

    Department of Vascular Surgery Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

    1 shared publication
  • Chunyang Lou

    Zhengzhou University - Department of Vascular and Endovascular Surgery

    1 shared publication

Latest Publications

  • Nanoparticle IL-33 Covalent Pericardial Patch Inhibits Pseudoaneurysm Formation after Aortic Patch Angioplasty

    by Liwei Zhang, Lingyi Che, Zhiwen Zhang, Bin Liu, Zhao Liu, Hai Feng

    Background: Pseudoaneurysm is a complication of interventional surgery and other vascular injuries; the formation mechanism is unclear. The purpose of this study was to explore the mechanism of IL-33 in pseudoaneurysms and develop a pericardial patch coated with IL-33 PLGA nanoparticles to inhibit pseudoaneurysm formation Methods: Rats were sacrificed on day 30 to observe the formation of pseudoaneurysms in NP-IL-33, NP-TGFβ-coated, and control groups. Histological staining was used to evaluate the size and breakage of the elastic fibers. Immunofluorescence was used to assess proliferation, macrophage infiltration, and TGF-β pathway activity. NP-SB431542 and LPS hydrogel were initially applied to assess the effect of the TGF-β inhibitor on IL-33 and the effect of IL-33 on macrophage infiltration. Results: NP-TGF-β (p = 0.0041) and NP-IL-33 (p = 0.0246) coated pericardial patches can inhibit the formation of pseudoaneurysms. The release of IL-33 can increase the expression of TGF-β (p = 0.0009), reduce the infiltration of M1 macrophages (p = 0.0009), and save the formation of pseudoaneurysms caused by the TGF-β inhibitor SB431542. Conclusions: IL-33 reduced the formation and progression of pseudoaneurysms by enhancing TGF-β pathway activity. A pericardial patch coated with IL-33 PLGA nanoparticles can reduce pseudoaneurysm formation after patch angioplasty, which has potential for clinical application.

  • PLGA Nanoparticle Rapamycin- or Necrostatin-1-Coated Sutures Inhibit Inflammatory Reactions after Arterial Closure in Rats

    by Liwei Zhang, Wang Wang, Boao Xie, Peng Sun, Shunbo Wei, Haoliang Wu, Cong Zhang, Jingan Li, Zhuo Li, Hualong Bai

    Background: The inflammatory reaction of sutures and oozing after arterial closure depends on the suture material and the amount of oozing surrounding the sutures. Anti-inflammation coatings have been proven to be an effective strategy to decrease this reaction. The aim of this study was to establish an arterial closure oozing model in rats and to test the effect of poly (lactic-co-glycolic acid) (PLGA) nanoparticle (NP) rapamycin- or necrostatin-1(NEC-1)-coated sutures on the inflammatory reaction after arterial closure. Methods and Materials: A 10 mm arteriotomy was carried out on the carotid artery of Sprague–Dawley rats and closed using 11-0 sutures. PLGA NP-rapamycin and NEC-1 were made. The 11/0 nylon sutures were coated with PLGA NP-rapamycin and NEC-1. Sutures were examined by scanning electron microscopy, hemolysis test, and cumulative release. The carotid arteriotomy was closed using uncoated PLGA NP-rapamycin- and NP-NEC-1-coated sutures. The carotid artery was harvested on day 7. Tissues were examined by histology and immunohistochemistry. Results: There were severe inflammatory reactions in the oozing arteries compared to the normal healing arteries (P = 0.0192). PLGA NP-rapamycin- and NEC -1-coated sutures reduced foreign body reaction compared to the uncoated sutures. There were significantly smaller number of CD3 (P = 0.0068), CD45 (P = 0.0300), and CD68 (P = 0.0011) cells in the PLGA NP-rapamycin- and NP-NEC-1-coated groups compared to the uncoated group. There was a smaller number of p-mTOR (P = 0.0198)-positive cells in the PLGA NP-rapamycin-coated group compared to the uncoated group. There was a smaller number of TNFα (P = 0.0198)-positive cells in the PLGA NP-NEC-1-coated group compared to the uncoated group. Conclusions: In this rat carotid artery oozing model, PLGA NP-rapamycin- or NP-NEC-1-coated sutures can inhibit inflammatory reaction and foreign body reaction. Although this was a small rodent animal experiment, this coated suture may have a potential clinical application in the future.


  • Open Access

    Il-33 Inhibits Abdominal Aortic Aneurysm Formation Through the Pparγ-Ra Signaling Pathway

    by Liwei Zhang, Cong Zhang, Shunbo Wei, Zhiwei Wang, Mingxing Li, Haoliang Wu, Boao Xie, Chunyang Lou, Jing’an Li, Hualong Bai

    Objective: To explore the mechanism of IL-33 inhibiting aneurysms by detecting the key mechanism of phenotypic transformation of cells. To confirm the potential therapeutic function of IL-33 in a rat aortic pericardial patch angioplasty induced aneurysm model. Materials and methods: Based on the fact that IL-33 can promote M2 polarization, this study explored the related mechanisms of IL-33 based on the polarization of macrophages. First, we obtained transcriptome, proteome, and phosphorylated proteome data related to the polarization of macrophages induced by IL4 and LPS. WGCNA was used to obtain key proteins in macrophage M2 polarization induced by IL4. Time-course phosphoproteomics data were processed using gene-centric analysis to identify key proteins. Further, pathways were identified by enrichment analysis. Combined with the GSEA and KEGG pathway diagrams, we constructed the IL-33/ERK/PPARγ/RA signaling pathway. Vascular smooth muscle cells (VSMCs) were also regulated by this mechanism based on AAA scRNA-seq, and cell trajectory analysis was used to explore the regulatory effect of this pathway on VSMCs. Human AAA samples were stained by EVG and immunohistochemistry. S-D rat pericardial patch angioplasty induced aneurysm model was used, control and IL-33 coated patches were implanted in the rat aorta and harvested at day 30; samples were stained by histology, immunohistochemistry, and immunofluorescence. Results: Retinoic acid pathway plays a key role in the M2 polarization of macrophages, which also maintaining VSMC homeostasis. IL-33 can activate ERK/PPAR pathway, activate the retinoic acid pathway, and block endoplasmic reticulum (ER) stress. In human and rat, IL-33-RA pathway markers were significantly increased in AAA; the ER stress markers were aslo significantly increased in the AAA compared to the aorta. IL-33 coated patch can decrease AAA formation, promote M2 macrophages polarization and inhibit M1 polarization; IL-33 can also maintain VSMCs homeostasis, and inhibit secretory transformation by activating PPARγ -RA pathway. Conclusion: IL-33 activates the ERK/PPAR/ retinoic acid pathway, promotes macrophage M2 polarization, inhibits macrophage M1 polarization by inhibiting ER stress; IL-33 can also maintains VSMCs homeostasis, and inhibits secretory VSMCs transformation. IL-33 can effectively inhibit AAA formation in rat, it may be a potential therapeutic target in clinic. Funding Information: This study was funded by the National Natural Science Foundation of China (Grant No: 81870369), Health Science and Technology Innovation Fund for Distinguished Young Scholars of Henan Province (YXKC2021040), Introducing Foreign Intelligence Project of Henan Province (HNGD2022029). Declaration of Interests: Authors declare that they have no conflict of interest. Ethics Approval Statement: All protocols involving human biospecimens complied with all relevant ethical regulations, and informed consent was not needed. The study was approved by the Ethics Committee of First Affiliated Hospital of Zhengzhou University. Since the samples used were discarded samples, so there is no need for the informed consent.